NEW YORK (GenomeWeb News) – The American Civil Liberties Union and the Public Patent Foundation have asked the US Supreme Court to take up the question of gene patenting for a second time by looking again at the patentability of Myriad Genetics' claims on genes that predict risk of breast and ovarian cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.